- Home
- ACAD vs OGS Comparison
ACAD vs OGS Comparison
Compare ACAD & OGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- OGS
- Stock Information
- Founded
- ACAD 1993
- OGS 1906
- Country
- ACAD United States
- OGS United States
- Employees
- ACAD N/A
- OGS N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- OGS Oil/Gas Transmission
- Sector
- ACAD Health Care
- OGS Utilities
- Exchange
- ACAD Nasdaq
- OGS Nasdaq
- Market Cap
- ACAD 4.0B
- OGS 4.3B
- IPO Year
- ACAD 2004
- OGS N/A
- Fundamental
- Price
- ACAD $25.74
- OGS $77.00
- Analyst Decision
- ACAD Buy
- OGS Buy
- Analyst Count
- ACAD 20
- OGS 6
- Target Price
- ACAD $28.63
- OGS $77.75
- AVG Volume (30 Days)
- ACAD 2.0M
- OGS 504.8K
- Earning Date
- ACAD 08-06-2025
- OGS 08-05-2025
- Dividend Yield
- ACAD N/A
- OGS 3.56%
- EPS Growth
- ACAD 615.00
- OGS 6.57
- EPS
- ACAD 1.33
- OGS 4.21
- Revenue
- ACAD $1,018,885,000.00
- OGS $2,330,032,000.00
- Revenue This Year
- ACAD $13.28
- OGS $23.44
- Revenue Next Year
- ACAD $10.88
- OGS $4.32
- P/E Ratio
- ACAD $18.70
- OGS $17.85
- Revenue Growth
- ACAD 14.41
- OGS 13.43
- 52 Week Low
- ACAD $13.40
- OGS $66.38
- 52 Week High
- ACAD $25.88
- OGS $82.25
- Technical
- Relative Strength Index (RSI)
- ACAD 66.52
- OGS 63.98
- Support Level
- ACAD $24.47
- OGS $73.91
- Resistance Level
- ACAD $25.88
- OGS $76.01
- Average True Range (ATR)
- ACAD 0.71
- OGS 1.29
- MACD
- ACAD 0.00
- OGS 0.13
- Stochastic Oscillator
- ACAD 94.62
- OGS 96.79
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.